| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/12/2006 | US20060008465 Novel methods for therapeutic vaccination |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613323A1 Pharmaceutical compositions comprising apomorhine for pulmonary inhalation |
| 01/11/2006 | EP1613293A1 Extended transdermal contraceptive regimens |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720054A Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718237A Traditional Chinese medicine composition for treating colpitis and cervicitis, prepn. method and quality standard therefor |
| 01/11/2006 | CN1718201A Medicine used for tonifying-kidney strengthening-yang and replenishing-qi to invigorate the spleen, and its prepn. method |
| 01/11/2006 | CN1718198A Pharmaceutical composition, prepn. method and medical use thereof |
| 01/11/2006 | CN1718197A Pharmaceutical composition contg .bifidobacterium, prepn. method and medical use thereof |
| 01/11/2006 | CN1718196A Pharmaceutical composition contg. lactobacillus, prepn. method and medical use thereof |
| 01/11/2006 | CN1235908C 16,17-carbocyclic condensed steroid compounds having seletive estrogenic activity |
| 01/11/2006 | CN1235619C Medicine for female infertility |
| 01/11/2006 | CN1235609C Traditional Chinese medicine preparation for curing gynecopathy |
| 01/11/2006 | CN1235606C Vaginitis-treating compound Chinese and Western medicine preparation |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/10/2006 | US6984665 Administering 4-chloro-1-(p-(2-hydroxyethoxy)phenyl)-1,2-diphenyl-1-butene or a geometric isomer, a stereoisomer, a salt, an ester thereof or a metabolite thereof |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/05/2006 | WO2006000158A1 The use of laetispicine for manufacture of pharmaceutical composition |
| 01/05/2006 | US20060004190 Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
| 01/05/2006 | US20060004082 6H-thieno'2, 3-b!pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh) |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004020 Pyrrolidine derivatives as oxytocin antagonists |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003992 New drug combinations |
| 01/05/2006 | CA2571529A1 Substituted diketopiperazines as oxytocin antagonists |
| 01/05/2006 | CA2571527A1 Piperazinediones as oxytocin receptor antagonists |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
| 01/04/2006 | EP1611892A2 Pharmaceutical compositions comprising drospirenone |
| 01/04/2006 | EP1610803A2 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 01/04/2006 | EP1610799A1 Compositions comprising hyaluronic acid for the prevention of urogenital infections |
| 01/04/2006 | EP1610789A1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | CN1717239A Transdermal therapeutic system containing testosterone and method for the production thereof |
| 01/04/2006 | CN1714866A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 01/04/2006 | CN1714816A Vagina contracting agent |
| 01/04/2006 | CN1714790A Fibrauretine transfusion preparation and its preparing method |
| 01/04/2006 | CN1234721C Androgenic 7-substituted 11-halogen steroids |
| 01/04/2006 | CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines |
| 01/04/2006 | CN1234708C Novel imidazotriazinones and the use thereof |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234406C Medicine for treating chronic pelvic inflammation and its preparing process |
| 01/04/2006 | CN1234382C Medicine ointment for treating women's leukoplakia vulvae and valval pruritus |
| 01/04/2006 | CN1234373C Medicinal preparation containing lactobacillus acidophilus and preparation process thereof |
| 01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
| 01/04/2006 | CN1234350C Estrogen plaster used on pessary or intrauterine device |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2329005C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 01/03/2006 | CA2203379C Cgmp-pde inhibitors for the treatment of erectile dysfunction |
| 12/29/2005 | WO2005025356A3 Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288355 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 12/29/2005 | US20050288264 Dosage Regimen and Pharmaceutical Composition for Emergency Contraception |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | US20050287195 Transdermal drug delivery systems |
| 12/28/2005 | EP1609803A1 Modified antibody against cd22 and utilization thereof |
| 12/28/2005 | EP1609470A1 Nasal delivery of apomorphine |
| 12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 12/28/2005 | EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 12/28/2005 | EP1355650B1 Combination of active ingredients containing alfuzosine and apomorphine |
| 12/28/2005 | EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 12/28/2005 | EP1173433B1 Cyanopyrroles as progesterone receptor agonists |
| 12/28/2005 | EP1129089B1 Spiro-indolines as y5 receptor antagonists |
| 12/28/2005 | EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/28/2005 | EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
| 12/28/2005 | EP0778836B1 Substituted 9-alkyladenines |
| 12/28/2005 | CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 12/28/2005 | CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |